ea0081rc4.1 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022
Feola Tiziana
, Gianno Francesca
, Verrico Monica
, Giangaspero Felice
, Tomao Silverio
, Colonnese Claudio
, Esposito Vincenzo
, Isidori Andrea
, Minniti Giuseppe
, Jaffrain-Rea Marie-Lise
Introduction: Metastatic pituitary neuroendocrine tumors (PitNETs) or pituitary carcinomas are rare and challenging conditions. We present a recent and encouraging observation of a temozolomide (TMZ)-resistant clinically non-functioning metastatic PitNET showing a remarkable response to the anti-PDL1 drug Pembrolizumab.Case presentation: A 57-years-old man had transsphenoidal surgery in November 2012 for a large non-functioning intra/suprasellar mass rev...